OakChart

Pennant Group Inc

PNTGHealthcare·Medical Care Facilities·USA·Small·NASD·Nov 11 • 3:59 PM ET

36.80+0.06 (0.16%)
2026-11-11 23:41 CET
Market cap
1,290.76 USD m
Revenue, TTM
1,174.92 USD m
Net income, TTM
35.88 USD m
Free cash flow, TTM
18.70 USD m
EPS diluted, TTM
1.00
P/E
36.82
Compare

Price

PNTG against its 20, 50 and 200-day averages
2050200miss
30.0035.0040.0045.00850K1.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PNTGclose 36.8020-day 40.6950-day 40.12200-day 35.8136.8052w high

16.8% under the 52-week high of 44.24 on 4 Nov 2026. 52-week low 24.21 on 11 Nov 2025. Last 15 sessions, 25.4% high to low

Volume 0.83× normal · the line is the 50-bar volume average

Profile

PNTG
52-week range, 63% of the way up
24.2144.24

The Pennant Group, Inc. is a holding company, which engages in the provision of healthcare services to patients of all ages. It operates through the Home Health and Hospice Services, and Senior Living Services segments. The Home Health and Hospice Services segment provides a combination of clinical care services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services. The Senior Living Services segment deals with assisted and independent living and memory care businesses. The company was founded on January 24, 2019 and is headquartered in Eagle, ID.

IndexRUT
Employees9700
IPOOct 01, 2019
Beta1.32
ATR, 14d1.93
Rel volume0.83
Short float3.51%
Insider own5.06%
Inst own95.79%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.29B
Enterprise Value1.81B
Income35.88M
Sales1.17B
Book/sh10.71
Cash/sh0.52
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees9700
IPOOct 01, 2019

Ratios

P/E36.82
Forward P/E23.25
PEG1.52
P/S1.10
P/B3.43
P/C70.30
P/FCF69.14
EV/EBITDA21.24
EV/Sales1.54
Quick Ratio1.18
Current Ratio1.18
Debt/Eq1.30
LT Debt/Eq1.20
Option/ShortYes / Yes

Earnings

EPS (ttm)1.00
EPS next Y1.58
EPS next Q0.36
EPS this Y18.16%
EPS next Y13.52%
EPS next 5Y15.28%
EPS past 3/5Y56.07% 9.97%
Sales past 3/5Y26.05% 19.37%
EPS Y/Y TTM33.07%
Sales Y/Y TTM38.67%
EPS Q/Q53.65%
Sales Q/Q31.96%
EarningsNov 04 AMC
EPS/Sales Surpr.-2.07% 0.97%

Ownership

Insider Own5.06%
Insider Trans-1.00%
Inst Own95.79%
Inst Trans-1.23%
ROA3.99%
ROE10.28%
ROIC4.34%
Gross Margin13.03%
Oper. Margin6.24%
Profit Margin3.05%
SMA20-9.57%
SMA50-8.28%
SMA2002.77%
Trades-

Technical

Shs Outstand35.07M
Shs Float33.36M
Short Float3.51%
Short Ratio3.21
Short Interest1.17M
52W High44.24 -16.82%
52W Low24.21 52.00%
Volatility7.83% 4.19%
ATR (14)1.93
RSI (14)38.57
Beta1.32
Rel Volume0.83
Avg Volume364.50K
Volume304,217

Performance

Perf Week-16.44%
Perf Month-8.34%
Perf Quarter-4.76%
Perf Half Y3.40%
Perf YTD30.73%
Perf Year45.68%
Perf 3Y197.01%
Perf 5Y38.87%
Perf 10Y-
Recom1.00
Target Price48.00
Prev Close36.74
Price36.80
Change %0.16%

Analyst ratings

latest 10 of 15
DateActionAnalystRating changeTargetImplied
Dec 08, 2025InitiatedWWilliam BlairOutperform
Dec 02, 2025UpgradeTTruistHold → Buy$34-7.6%
Nov 18, 2025UpgradeWWells FargoEqual Weight → Overweight$31-15.8%
Oct 24, 2025InitiatedJJefferiesBuy$30-18.5%
Dec 19, 2024InitiatedWWells FargoEqual Weight$33-10.3%
Jan 05, 2024UpgradeSStephensEqual-Weight → Overweight$14 → $18-51.1%
Feb 27, 2023UpgradeSStifelHold → Buy$15 → $16-56.5%
Aug 25, 2022InitiatedOOppenheimerOutperform$22-40.2%
Jun 21, 2022DowngradeSStephensOverweight → Equal-Weight$23 → $17-53.8%
Mar 01, 2022DowngradeSStifelBuy → Hold$32 → $18-51.1%

Peers

Mkt cap
TickerCompanyMkt cap
ADUSAddus HomeCare Corp2.34B
AVAHAveanna Healthcare Holdings Inc2.86B
ENSGEnsign Group Inc10.86B
BKDBrookdale Senior Living Inc2.21B
CHEChemed Corp7.17B
NHCNational Healthcare Corp3.30B
SNDASonida Senior Living Inc1.67B
PACSPACS Group Inc7.95B
BTSGBrightSpring Health Services Inc14.45B
INNVInnovAge Holding Corp1.30B

Insider trading

latest 14 of 17
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Gochnour John JChief Operating OfficerOct 23 '26Option Exercise6.105,94836,283151,412Oct 27 06:16 PM
Cheney Kirk SterlingEVP, GC and Corp SecyAug 06 '26Sale38.521,39353,66118,401Aug 10 03:49 PM
Guerisoli BrentChief Executive OfficerAug 06 '26Sale38.524,285165,06799,544Aug 10 03:49 PM
Steik Jason PaulChief Clinical OfficerAug 06 '26Sale38.521,39453,70015,106Aug 10 03:48 PM
Cheney Kirk SterlingOfficerAug 06 '26Proposed Sale38.521,39353,662Aug 06 03:39 PM
Guerisoli BrentOfficerAug 06 '26Proposed Sale38.524,285165,069Aug 06 03:28 PM
Steik Jason PaulOfficerAug 06 '26Proposed Sale38.521,39453,700Aug 06 03:25 PM
Guerisoli BrentChief Executive OfficerJul 10 '26Option Exercise4.546,24828,366106,988Jul 14 12:16 PM
Guerisoli BrentChief Executive OfficerJul 10 '26Sale41.563,159131,304103,829Jul 14 12:16 PM
Guerisoli BrentOfficerJul 10 '26Proposed Sale41.573,159131,304Jul 10 10:14 AM
Guerisoli BrentChief Executive OfficerJul 07 '26Option Exercise4.546,24928,370103,905Jul 09 11:32 AM
Guerisoli BrentChief Executive OfficerJul 07 '26Sale40.513,165128,214100,740Jul 09 11:32 AM
Guerisoli BrentOfficerJul 07 '26Proposed Sale40.513,165128,214Jul 07 11:41 AM
Guerisoli BrentChief Executive OfficerMay 22 '26Option Exercise3.848,92634,27699,910May 27 03:41 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M

News

latest 14 of 200
  • Pennant Group Matches Estimates As Home Health Strength Offsets Senior Living Stumble And Softer Guidance Tone (Earnings Whispers) -9.17%
  • Pennant Reports Third Quarter 2026 Results (GlobeNewswire) +6.92%
  • Pennant Announces Third Quarter 2026 Earnings Release and Call (GlobeNewswire)
  • Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California (GlobeNewswire) +6.28% -5.77%
  • Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference (GlobeNewswire)
  • Pennant Group Inc (PNTG) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
  • Pennant Reports Second Quarter 2026 Results (GlobeNewswire)
  • Pennant Acquires River Centre Assisted Living in Tucson, Arizona (GlobeNewswire)
  • Pennant Announces Second Quarter 2026 Earnings Release and Call (GlobeNewswire)
  • The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut (GlobeNewswire)
  • Pennant Expands Senior Living Presence with Pleasant Hill, California Community (GlobeNewswire)
  • Pennant Group to Participate in the 2026 RBC Global Healthcare Conference (GlobeNewswire)
  • Pennant Announces an Acquisition of Senior Living Community in Arizona (GlobeNewswire)
  • Pennant Reports First Quarter 2026 Results (GlobeNewswire) +9.84%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.3500.3570.260302.25299.347
2026Q22026-08-050.3600.3320.253297.98288.717
2026Q12026-05-060.3200.3090.238285.36280.757
2025Q42026-02-250.3400.3160.244289.32275.197
2025Q32025-11-050.3000.2870.172229.04222.16
2025Q22025-08-060.2700.2700.200219.5210.625
2025Q12025-05-060.2700.2400.221209.84201.464
2024Q42025-02-270.2400.2400.163188.89185.835
2024Q32024-11-060.2600.2300.198180.69174.374
2024Q22024-08-060.2400.2150.185168.75156.754
2024Q12024-05-060.2000.1700.161156.92146.214
2023Q42024-02-280.2200.2200.144145.95136.434
2023Q32023-11-070.2000.1950.145140.19130.574
2023Q22023-08-080.1800.1650.093132.28126.784
2023Q12023-05-040.1300.1450.061126.46122.254
2022Q42023-02-230.1800.1820.115124.67116.535

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.6100.5000.086338.53339.7
2020FY0.7700.7830.521390.95382.27
2021FY0.4600.5400.088439.69434.7
2022FY0.5700.5720.220473.24463.07
2023FY0.7300.7280.443544.89530.95
2024FY0.9400.9350.705695.24689.21
2025FY1.1801.1500.840947.71930.08
2026FY-1.394--1,185
2027FY-1.583--1,276
2028FY-1.808--1,349

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-05700303.93299.6307.99
2026Q4S2026-11-04700303.9300308.15
2026Q4S2026-11-01700303.9300308.15
2026Q4S2026-10-20710303.9300308.15
2026Q4S2026-08-18750303.9300308.15
2026Q4S2026-08-15640304.54301.8308.15
2026Q4S2026-08-10740303.45296.9308.15
2026Q4S2026-08-06740303.09296.9308.15
2026Q4S2026-07-21700299.93296.8302.65
2026Q4S2026-07-13713299.93296.8302.65
2026Q4S2026-07-09713299.87296.8302.65
2026Q4S2026-05-12713299.95296.8302.65
2026Q4S2026-05-07713299.96296.8302.65
2026Q4S2026-05-01720301.93296.76307.75

Estimate history

EPS, annual0.3520.560.0860.5210.0880.220.4430.7050.8380.9994
Period201720182019202020212022202320242025TTM
EPS, quarterly0.1980.1630.2210.20.1720.2440.2380.2530.265
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual250.991286.058338.531390.953439.694473.241544.891695.24947.7051174.92
Period201720182019202020212022202320242025TTM
Sales, quarterly180.688188.892209.842219.501229.039289.323285.364297.984302.251
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual282828.43528.24328.49929.69229.94834.37334.62635.074
Period201720182019202020212022202320242025MRQ
Shares, quarterly30.30834.37334.44534.4934.5734.62634.74634.84835.074
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,174.92947.71695.24544.89473.24439.69390.95338.53286.06
Cost of Goods Sold Incl. D&A1,021.86825.24607.60482.99419.56398.74340.74297.73246.58
Gross Profit153.07122.4787.6461.9153.6940.9550.2240.8039.47
Selling, General and Administrative Excl. Other79.7465.3749.5036.1933.1734.1729.5720.7218.84
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income73.3357.1038.1425.7120.516.7820.6420.0920.63
Interest Expense13.296.686.965.923.821.941.240.410.00
Unusual Expense5.266.210.710.480.812.091.7314.42-
Net Income Before Taxes57.3945.6331.3719.588.892.7317.905.2620.63
Income Taxes14.7411.877.035.671.650.582.352.084.35
Consolidated Net Income42.6433.7624.3413.917.242.1515.553.1716.28
Net Income From Continuing Operations35.8829.5822.5613.386.642.7015.742.5515.68
Net Income35.8829.5822.5613.386.642.7015.742.5515.68
EPS (Recurring)1.090.960.720.450.240.140.560.430.56
EPS (Basic, Before Extraordinaries)1.030.860.720.450.230.090.560.090.56
EPS (Diluted)1.000.840.700.440.220.090.520.090.56
EBITDA85.1065.6444.2630.8425.4111.5725.3224.1223.59
Non-Operating Income (Expense)2.601.420.890.27-7.00-0.020.230.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.667.066.514.402.447.336.082.471.88
Price To Earnings Ratio36.7636.7638.5533.57440.96279.42111.12365.41-
Price To Sales Ratio1.211.051.220.770.701.614.492.89-
Gross Margin13.0312.9212.6111.3611.349.3112.8412.0513.80
Operating Margin6.246.025.494.724.331.545.285.937.21
Net Margin3.053.123.242.461.400.614.030.755.48
Shares Outstanding35.0734.6334.3729.9529.6928.5028.2428.4328.00
Market Capitalization1,290.761,290.76910.92416.58325.85657.251,636.68920.90882.47

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue302.25297.98285.36289.32229.04219.50209.84188.89
Cost of Goods Sold Incl. D&A264.06257.92247.97251.91199.56191.42182.35165.72
Gross Profit38.1940.0737.4037.4229.4828.0827.4923.18
Selling, General and Administrative Excl. Other20.9921.2619.3318.1516.2116.4714.5513.58
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income17.2018.8018.0619.2713.2711.6112.949.60
Interest Expense3.623.353.073.251.021.201.210.65
Unusual Expense1.191.610.761.703.091.130.290.29
Net Income Before Taxes14.1914.8314.0914.279.4010.5811.388.60
Income Taxes3.123.943.793.902.522.602.852.07
Consolidated Net Income11.0710.9010.2910.386.897.988.526.53
Net Income From Continuing Operations9.649.088.528.646.087.087.785.76
Net Income9.649.088.528.646.087.087.785.76
EPS (Recurring)0.290.280.250.280.230.220.230.17
EPS (Basic, Before Extraordinaries)0.280.260.250.250.180.210.230.17
EPS (Diluted)0.260.250.240.240.170.200.220.16
EBITDA20.8821.9120.6821.6315.3413.8314.8311.43
Non-Operating Income (Expense)1.800.99-0.15-0.050.231.30-0.07-0.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.622.331.991.721.941.721.702.23
Price To Earnings Ratio36.7643.2436.4037.2132.2538.9435.5738.55
Price To Sales Ratio1.211.211.071.051.051.321.181.35
Gross Margin12.6313.4513.1012.9312.8712.7913.1012.27
Operating Margin5.696.316.336.665.805.296.175.08
Net Margin3.193.052.992.992.663.233.713.05
Shares Outstanding35.0734.8534.7534.6334.5734.4934.4534.37
Market Capitalization1,290.761,284.661,056.53973.81871.651,028.90865.91910.92

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments17.0224.256.062.085.190.040.400.040.04
Short Term Receivables123.1181.3061.1253.4253.9447.2232.1824.4722.25
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets27.2717.3112.9018.3216.7112.346.104.614.42
Total Current Assets167.41122.8680.0873.8275.8459.6038.6829.1226.70
Net Property, Plant & Equipment343.52313.88291.52287.49317.79326.53330.9710.468.79
Total Investments and Advances0.000.000.000.000.000.531.400.000.00
Intangible Assets436.69225.31158.76138.11128.00113.9374.7456.1150.85
Deferred Tax Assets0.4886.8380.7582.4892.0690.44---
Other Assets20.0917.489.3410.544.834.291.962.461.95
Total Assets968.18766.36620.44592.45618.51595.32447.7598.1588.29
Short Term Debt Incl. Current Port. of LT Debt30.8319.6717.1216.6316.1214.1112.290.000.00
Accounts Payable25.1718.7410.8413.6510.559.768.654.393.08
Other Current Liabilities91.2663.2943.5939.9744.9665.1530.2525.1623.18
Total Current Liabilities147.26101.7071.5570.2571.6489.0251.1929.5526.25
Long Term Debt428.99253.42312.51309.93339.12304.89322.570.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.1588.7082.6180.3388.2188.35---
Other Liabilities17.5210.578.266.285.2911.902.883.322.12
Total Liabilities593.93454.39474.93466.79504.26494.15376.6432.8628.37
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity332.60293.28140.34121.01110.2096.5871.1155.8655.00
Total Shareholders Equity332.60293.28140.34121.01110.2096.5871.1155.8655.00
Accumulated Minority Interest41.6518.685.184.644.044.590.009.434.92
Total Equity374.25311.96145.51125.66114.24101.1771.1165.2959.92
Total Liabilities & Stockholders Equity968.18766.36620.44592.45618.51595.32447.7598.1588.29
Book Value Per Share9.618.534.694.083.873.422.501.991.96
Tangible Book Value Per Share-3.011.98-0.61-0.58-0.62-0.61-0.13-0.010.15
Full-Time Employees9,7007,0005,7915,3356,4415,2234,7003,151-
Price to Book Ratio3.434.753.102.805.9716.9813.2212.41-
Return on Assets3.413.252.211.100.443.020.9316.82-
Return on Equity9.4510.4010.245.752.6118.784.0128.30-
Return on Invested Capital3.884.132.951.540.603.920.6528.0817.94
Quick Ratio1.141.211.121.051.060.670.760.991.02
Current Ratio1.141.211.121.051.060.670.760.991.02

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income42.6433.7624.3413.917.242.1515.553.1716.28
Depreciation11.778.546.125.134.904.784.674.112.96
Other Funds (Non Cash)11.469.785.186.614.7113.989.154.242.73
Funds from Operations68.9749.8934.4529.6518.5519.1627.1711.6021.97
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-4.46-1.590.933.44-9.50-37.3822.95-2.051.30
Cash from Operating Activities64.5048.2935.3833.099.04-18.2250.139.5523.27
Capital Expenditures-45.80-22.00-20.37-8.11-14.17-6.30-7.25-6.71-3.60
Net Assets From Acquisitions-151.12-204.02-48.42-21.38-10.13-13.55-33.19-18.78-5.32
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-28.38-2.89-2.34-0.20-0.050.00-0.53-1.400.00
Purchase of Investments-28.38-2.89-2.34-0.20-0.050.00-0.53-1.400.00
Sale Or Maturity of Investments--0.000.000.000.000.00-0.00
Other Uses0.000.000.00-0.540.00-0.27-0.650.00-0.56
Other Sources-0.340.940.450.000.110.000.000.430.00
Cash from Investing Activities-221.47-227.97-70.68-30.22-24.24-20.12-41.62-26.46-9.48
Cash Dividends Paid0.000.000.000.000.000.000.00-11.600.00
Change in Capital Stock5.730.55119.000.581.080.881.1410.42-13.79
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-2.69-15.77
Sale of Common Pref Stock5.730.55119.000.581.080.881.1413.111.97
Proceedsfrom Stock Options0.000.00118.150.000.000.000.0013.081.97
Issuance or Reduction of Debt, Net172.05173.80-65.510.5311.0042.61-10.5020.000.00
Change in Long Term Debt172.05173.80-65.510.5311.0042.610.000.000.00
Issuance of Long Term Debt508.30471.80308.99182.03129.50124.110.000.000.00
Reduction of Long Term Debt-336.25-298.00-374.50-181.50-118.50-81.500.000.000.00
Net Financing Active Other Cash Flow-4.76-1.890.000.000.000.000.490.000.00
Other Financing Activities Uses-4.76-1.890.000.000.000.00-0.070.000.00
Cash from Financing Activities173.02172.4653.491.1112.0843.49-8.8717.27-13.79
Net Change in Cash16.05-7.2218.193.98-3.115.15-0.360.360.01
Free Cash Flow18.7026.3015.0124.98-5.13-24.5342.872.8419.67
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow75.8737.8156.5316.82--40.94--
Deferred Taxes & Investment Tax Credit--2.19-1.194.001.70-1.75-2.200.080.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments18.3915.274.9117.022.3414.38
Short Term Receivables130.84133.18122.82123.1196.0895.72
Inventories0.000.000.000.000.000.00
Other Current Assets29.8435.1425.0927.2715.5517.27
Total Current Assets179.07183.59152.82167.41113.97127.37
Net Property, Plant & Equipment379.87369.54344.71343.52330.15326.42
Total Investments and Advances30.1828.800.000.000.000.00
Intangible Assets437.06435.23436.69436.69282.99273.79
Deferred Tax Assets0.590.840.050.480.850.03
Other Assets16.0519.2922.2120.0925.6923.80
Total Assets1,042.821,037.29956.48968.18753.64751.42
Short Term Debt Incl. Current Port. of LT Debt38.3038.0536.8530.8321.9720.67
Accounts Payable27.5426.2422.8025.1721.6319.21
Income Tax Payable0.000.00--2.223.06
Other Current Liabilities85.9088.1168.9391.2663.5262.00
Total Current Liabilities151.73152.41128.57147.26109.35104.94
Long Term Debt450.63457.50417.30428.99280.85292.78
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities2.841.801.320.15-1.14
Other Liabilities17.8521.1419.8617.5220.4018.93
Total Liabilities623.05632.85567.05593.93410.60417.79
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity375.82359.20346.01332.60321.91313.30
Total Shareholders Equity375.82359.20346.01332.60321.91313.30
Accumulated Minority Interest43.9545.2443.4241.6521.1320.32
Total Equity419.76404.44389.44374.25343.04333.63
Total Liabilities & Stockholders Equity1,042.821,037.29956.48968.18753.64751.42
Book Value Per Share10.7110.319.969.619.319.08
Tangible Book Value Per Share-1.75-2.18-2.61-3.011.131.15
Full-Time Employees---9,700--
Price to Book Ratio3.433.713.173.022.783.39
Return on Assets3.993.613.573.413.813.96
Return on Equity10.289.619.349.4510.8711.44
Return on Invested Capital1.171.111.121.131.011.17
Quick Ratio1.181.201.191.141.041.21
Current Ratio1.181.201.191.141.041.21

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income11.0710.9010.2910.386.897.98
Depreciation3.693.112.622.362.062.22
Other Funds (Non Cash)2.173.313.152.832.841.55
Funds from Operations18.2217.0217.6516.089.8310.09
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital6.904.81-21.054.884.0924.56
Income Taxes Payable0.00-1.901.90--0.841.17
Cash from Operating Activities25.1221.83-3.4020.9613.9234.64
Capital Expenditures-22.02-13.24-5.27-5.27-3.46-11.32
Net Assets From Acquisitions-1.83-2.090.00-147.20-9.200.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.03-23.96-0.330.04-2.130.56
Purchase of Investments0.00-28.10-0.330.04-2.130.56
Sale Or Maturity of Investments0.034.140.00-0.000.00
Other Uses0.41-0.410.000.000.000.00
Other Sources0.26-0.220.22-0.590.200.70
Cash from Investing Activities-23.15-39.92-5.38-153.02-14.60-10.05
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.661.161.27-0.360.080.44
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.661.161.27-0.360.080.44
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.7527.75-4.25147.80-11.00-15.50
Change in Long Term Debt0.7527.75-4.25147.80-11.00-15.50
Issuance of Long Term Debt62.00129.5088.50228.3079.0068.00
Reduction of Long Term Debt-61.25-101.75-92.75-80.50-90.00-83.50
Net Financing Active Other Cash Flow-3.27-0.46-0.34-0.69-0.46-0.36
Other Financing Activities Uses-3.27-0.46-0.34-0.69-0.46-0.36
Cash from Financing Activities1.1428.45-3.33146.75-11.38-15.43
Net Change in Cash3.1210.36-12.1114.69-12.059.16
Free Cash Flow3.108.59-8.6815.6910.4723.33
Price to Free Cash Flow75.8750.9626.7137.9437.1652.13

Revenue breakdown

United States2024: 695.24M 2025: 947.71M
Consolidation, Policy2024: 5.13M 2025: 6.24M
Home Health And Hospice Services2024: 515.34M 2025: 731.39M
Senior Living Services2024: 174.77M 2025: 210.08M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.51%1.2M33.4M324.40K
2026-10-153.46%1.1M33.2M313.20K
2026-09-303.56%1.2M33.2M316.89K
2026-09-153.19%1.1M33.2M289.95K
2026-08-312.64%0.9M33.2M294.21K
2026-08-142.32%0.8M33.2M291.20K
2026-07-312.01%0.7M33.2M292.07K
2026-07-152.20%0.7M33.0M287.59K
2026-06-302.36%0.8M33.0M266.30K
2026-06-151.91%0.6M33.0M246.10K
2026-05-291.82%0.6M33.0M250.87K
2026-05-151.92%0.6M33.0M274.93K
2026-04-301.97%0.6M33.0M263.81K
2026-04-151.94%0.6M33.3M297.59K
2026-03-312.42%0.8M33.0M293.99K
2026-03-133.18%1.0M33.0M285.62K
2026-02-273.05%1.0M33.0M280.98K
2026-02-132.82%0.9M32.9M266.46K
2026-01-302.61%0.9M32.9M277.43K
2026-01-152.67%0.9M32.9M267.87K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.5017.5022.000.005.9980.000.000.889-0.4850.011
call20.0015.0019.500.005.1630.000.000.866-0.4800.012
call22.5012.5017.000.004.4360.000.000.840-0.4680.014
call25.0010.0014.500.003.7870.000.000.812-0.4490.015
call30.005.009.5012.602.64010.000.000.740-0.3960.019
call35.000.505.002.621.8103.000.000.627-0.2970.022
call40.000.004.903.702.68910.000.000.499-0.3370.023
call45.000.004.700.573.2518.005.000.443-0.4170.023
call50.000.002.350.702.6615.000.000.298-0.3000.020
call55.000.004.700.653.0601.000.000.273-0.3300.019
put17.500.004.700.007.8870.000.00-0.111-0.4830.011
put20.000.004.700.006.8280.000.00-0.134-0.4780.012
put22.500.004.700.005.9230.000.00-0.160-0.4650.014
put25.000.004.700.005.1270.000.00-0.188-0.4470.015
put30.000.004.700.553.7484.000.00-0.260-0.3920.019
put35.000.054.901.702.6093.000.00-0.373-0.2930.022
put40.001.005.003.011.3353.000.00-0.501-0.3320.023
put45.006.0010.007.901.9357.000.00-0.557-0.4120.023
put50.0011.0015.000.002.4030.000.00-0.702-0.2940.020
put55.0016.0020.000.002.7910.000.00-0.727-0.3240.019

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-274Statement of changes in beneficial ownership of securities2026-10-23SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-31SCHEDULE 13GSEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-17SCHEDULE 13GSEC
2026-07-144Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-10144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800272.43K3
2026-0700259.52K2
2026-060000
2026-0500158.14K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.8.51%
Van Berkom & Associates Inc.6.20%
WASATCH ADVISORS LP5.16%
Turtle Creek Asset Management Inc.4.93%
VANGUARD CAPITAL MANAGEMENT LLC4.26%
PARADIGM CAPITAL MANAGEMENT INC/NY4.03%
GEODE CAPITAL MANAGEMENT, LLC2.71%
GOLDMAN SACHS GROUP INC2.56%
Provident Investment Management, Inc.2.56%
AMERIPRISE FINANCIAL INC2.52%

Funds

Fund% owned
Empower Small Cap Value Fund0.26%
Goldman Sachs Small Cap Growth Fund0.25%
Goldman Sachs Small Cap Equity Insights Fund0.17%
Goldman Sachs Small Cap Growth Insights Fund0.12%
Empower Core Strategies: U.S. Equity Fund0.10%
ALGER HEALTH SCIENCES FUND0.10%
Goldman Sachs Small Cap Value Insights Fund0.07%
Goldman Sachs U.S. Tax-Managed Equity Fund0.07%
Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund0.05%
BlackRock Advantage Small Cap Growth Fund0.05%

OakChart. PNTG. Cached 15 minutes.